Statement of Changes in Beneficial Ownership (4)
22 November 2014 - 4:11AM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
DANN MITCHELL
|
2. Issuer Name
and
Ticker or Trading Symbol
UROLOGIX INC
[
ULGX
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__
X
__ Director
_____ 10% Owner
_____ Officer (give title below)
_____ Other (specify below)
|
(Last)
(First)
(Middle)
C/O SAPIENT CAPITAL MANAGEMENT, LLC, PO BOX 1590
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
11/6/2014
|
(Street)
WILSON, WY 83014
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock
(1)
|
11/6/2014
|
|
A
|
|
45455
|
A
|
$0
|
530346
|
D
|
|
Common Stock
|
|
|
|
|
|
|
|
10358
|
I
|
By Trust
(2)
|
Common Stock
|
|
|
|
|
|
|
|
61684
|
I
|
By Trust
(3)
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Explanation of Responses:
|
(
1)
|
The restrictions on the restricted shares lapse one business day prior to the 2015 Annual Meeting of the Shareholders.
|
(
2)
|
The shares are held by the IRA Rollover FBO Mitchell Dann. The reporting person is the sole beneficiary of the IRA Rollover FBO Mitchell Dann.
|
(
3)
|
The reporting person is the sole trustee of the Glory Bowl Trust of which the reporting person's minor child is the beneficiary. The reporting person disclaims beneficial ownership of these securities.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
DANN MITCHELL
C/O SAPIENT CAPITAL MANAGEMENT, LLC
PO BOX 1590
WILSON, WY 83014
|
X
|
|
|
|
Signatures
|
Suzette McNally, Attorney-in-Fact for Mitchell Dann
|
|
11/21/2014
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Urologix (CE) (USOTC:ULGX)
Historical Stock Chart
From Apr 2024 to May 2024
Urologix (CE) (USOTC:ULGX)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Urologix Inc (CE) (OTCMarkets): 0 recent articles
More Urologix Inc News Articles